NCT06971744 2025-12-22
Autophagy Maintenance (AUTOMAIN)
Medical University of South Carolina
Phase 2 Recruiting
Clinical Trials
8 trialsNCT01959672 2023-10-10
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer
University of Nebraska
Phase 2 Completed
NCT02207439 2023-07-25
Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
Abramson Cancer Center at Penn Medicine
Phase 2 Completed
NCT01108666 2021-07-07
Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC)
Abramson Cancer Center at Penn Medicine
Phase 2 Terminated
NCT01925378 2020-11-12
A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia
The University of Texas Health Science Center, Houston
Phase 2 Withdrawn
NCT01065844 2019-10-09
Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck
University of Iowa
Phase 2 Completed
NCT02188537 2019-06-26
Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma
Swiss Cancer Institute
Phase 2 Completed
NCT00791336 2017-07-28
Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer
University of Iowa
Phase 2 Terminated